Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Oncostatin M targeting as approach for treating inflammatory pruritus

Nov. 30, 2021

IL-17A/IL-17RA interaction modulators patented by Janssen Pharmaceutica

Nov. 25, 2021

Chinese researchers synthesize new phosphodiesterase PDE4 inhibitors

Nov. 19, 2021

Vyne reports preclinical data on effect of VYN-201 on skin healing and repair

Nov. 5, 2021

Studies show that psoriasis is more than skin-deep

Nov. 2, 2021

Vyne reports findings with BET inhibitor VYN-201 in animal model and ex vivo human tissue study

Oct. 27, 2021

Titan Pharmaceuticals and MUSC enter research agreement on kappa-opioid receptor agonists

Oct. 14, 2021

Development of cell-penetrating asymmetric siRNAs for treating androgenetic alopecia

Oct. 8, 2021

IL-4 and IL-13 drive atopic dermatitis pathology by regulating sex steroid hormone synthesis

Oct. 4, 2021

Jiangsu Chia Tai Tianqing Pharmaceutical Group patents antibodies binding IL-4RA

Sep. 20, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...